DOJOLVIHCP.CA: Keyword Density Checker

Total words: 5819 | 2-word phrases: 1516 | 3-word phrases: 1744 | 4-word phrases: 1830

PAGE INFO

Title	Try to keep the title under 60 characters (36 characters) DOJOLVI® (triheptanoin) for LC-FAOD
Description	Try to keep the meta description between 50 - 160 characters (149 characters) DOJOLVI® (triheptanoin) is the first and only FDA approved treatment for patients diagnosed with long chain fatty acid oxidation disorders (LC-FAOD)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (4 characters) Home

ONE WORD PHRASES 729 Words

#	Keyword	Frequency	Density
1	the	94	12.89%
2	of	74	10.15%
3	dojolvi	67	9.19%
4	and	54	7.41%
5	to	52	7.13%
6	a	37	5.08%
7	in	36	4.94%
8	for	31	4.25%
9	patients	27	3.70%
10	is	25	3.43%

TWO WORD PHRASES 1516 Words

#	Keyword	Frequency	Density
1	of dojolvi	16	1.06%
2	fatty acid	14	0.92%
3	dojolvi in	13	0.86%
4	of the	12	0.79%
5	is a	11	0.73%
6	on the	9	0.59%
7	to a	9	0.59%
8	daily dosage	9	0.59%
9	patients with	9	0.59%
10	feeding tube	9	0.59%
11	in patients	9	0.59%
12	fatty acids	9	0.59%
13	download informational	8	0.53%
14	on a	8	0.53%
15	informational letter	8	0.53%
16	of a	7	0.46%
17	to 3	7	0.46%
18	in the	7	0.46%
19	pediatric patients	6	0.40%
20	dosage of	6	0.40%

THREE WORD PHRASES 1744 Words

#	Keyword	Frequency	Density
1	download informational letter	7	0.40%
2	of dojolvi in	6	0.34%
3	in patients with	5	0.29%
4	a source of	5	0.29%
5	source of calories	5	0.29%
6	total daily dosage	5	0.29%
7	of calories and	5	0.29%
8	calories and fatty	5	0.29%
9	pediatric patients with	4	0.23%
10	the reimbursement criteria	4	0.23%
11	mixing dojolvi into	4	0.23%
12	acid oxidation disorders	4	0.23%
13	dojolvi is a	4	0.23%
14	treatment of adult	4	0.23%
15	of adult and	4	0.23%
16	the treatment of	4	0.23%
17	and fatty acids	4	0.23%
18	into at least	4	0.23%
19	daily dosage of	4	0.23%
20	based on the	4	0.23%
21	at least 4	4	0.23%
22	on the reimbursement	4	0.23%
23	reimbursement criteria under	4	0.23%
24	up to 35	4	0.23%
25	criteria under the	4	0.23%
26	patients with longchain	3	0.17%
27	to learn more	3	0.17%
28	fatty acids for	3	0.17%
29	acids for the	3	0.17%
30	for the treatment	3	0.17%

FOUR WORD PHRASES 1830 Words

#	Keyword	Frequency	Density
1	a source of calories	5	0.27%
2	source of calories and	5	0.27%
3	of calories and fatty	5	0.27%
4	on the reimbursement criteria	4	0.22%
5	reimbursement criteria under the	4	0.22%
6	treatment of adult and	4	0.22%
7	the treatment of adult	4	0.22%
8	into at least 4	4	0.22%
9	calories and fatty acids	4	0.22%
10	pediatric patients with longchain	3	0.16%
11	divided into at least	3	0.16%
12	the reimbursement criteria under	3	0.16%
13	of dojolvi in patients	3	0.16%
14	up to 35 dci	3	0.16%
15	type to learn more	3	0.16%
16	fatty acid oxidation disorders	3	0.16%
17	based on the reimbursement	3	0.16%
18	administration of dojolvi in	3	0.16%
19	and fatty acids for	3	0.16%
20	least 4 times per	3	0.16%
21	for the treatment of	3	0.16%
22	as a source of	3	0.16%
23	performance and functionality can	3	0.16%
24	acids for the treatment	3	0.16%
25	the first and only	3	0.16%
26	most serious warnings and	2	0.11%
27	regularly monitor the feeding	2	0.11%
28	tubes manufactured of polyvinyl	2	0.11%
29	feeding tubes manufactured of	2	0.11%
30	in feeding tubes manufactured	2	0.11%
31	dojolvi in feeding tubes	2	0.11%
32	and environmental conditions do	2	0.11%
33	dysfunction performance and functionality	2	0.11%
34	icon initiate dojolvi at	2	0.11%
35	container most serious warnings	2	0.11%
36	this drug or to	2	0.11%
37	to this drug or	2	0.11%
38	or component of the	2	0.11%
39	ingredient or component of	2	0.11%
40	formulation including any nonmedicinal	2	0.11%

EXTERNAL LINKS

#	URL	Whois	Check
1	https://www.ultragenyx.com/COVID-19-information/	Whois	ultragenyx.com
2	https://www.ultragenyx.com/cookie-policy/	Whois	ultragenyx.com
3	https://www.ultragenyx.com/privacy-policy/	Whois	ultragenyx.com
4	https://www.dojolvi.ca/	Whois	dojolvi.ca
5	https://www.dojolvi.com/	Whois	dojolvi.com
6	https://www2.gov.bc.ca/gov/content/health/health-drug-coverage/pharmacare-for-bc-residents/what-we-cover/exceptional-funding-edrd	Whois	bc.ca
7	https://idbl.ab.bluecross.ca/idbl/DBL/60015.pdf	Whois	bluecross.ca
8	https://formulary.drugplan.ehealthsask.ca/PDFs/APPENDIXA.pdf	Whois	ehealthsask.ca
9	https://www.ontario.ca/page/get-coverage-prescription-drugs	Whois	ontario.ca
10	https://www.ramq.gouv.qc.ca/en/media/15701	Whois	qc.ca
11	https://src.healthpei.ca/sites/src.healthpei.ca/files/PB%20November%202023.pdf	Whois	healthpei.ca
12	https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/FormularyUpdates/NB-Drug-Plans-Bulletin-1119.pdf	Whois	gnb.ca
13	https://novascotia.ca/dhw/pharmacare/documents/Criteria-for-Exception-Status-Coverage.pdf	Whois	novascotia.ca
14	https://nlpdp.bell.ca/	Whois	bell.ca
15	https://nihb-ssna.express-scripts.ca/en/0205140506092019/16/160407	Whois	express-scripts.ca
16	https://www.ultracaresupport.ca/assets/pdf/DOJOLVI_UltraCare_Enrollment_Form_CA.pdf	Whois	ultracaresupport.ca
17	https://ultracaresupport.ca/	Whois	ultracaresupport.ca
18	https://www.ultragenyx.com/privacy-policy/	Whois	ultragenyx.com
19	https://www.ultragenyx.com/cookie-policy/	Whois	ultragenyx.com
20	https://www.ultragenyx.com/our-company/contact/	Whois	ultragenyx.com